14.08.2020 H&R GmbH & Co. KGaA  DE000A2E4T77

DGAP-News: H&R GmbH & Co. KGaA: Publishing of Half-Year Report 2020


 

DGAP-News: H&R GmbH & Co. KGaA / Key word(s): Quarterly / Interim Statement/Quarter Results
H&R GmbH & Co. KGaA: Publishing of Half-Year Report 2020

14.08.2020 / 09:12
The issuer is solely responsible for the content of this announcement.


H&R GmbH & Co. KGaA confirms business trend for the first half of 2020

- Operative earnings (EBITDA) at EUR 16.6 million significantly below prior-year
- Positive trend reversal since June / July
- Earnings expectation adjusted to up to EUR 45.0 million

Salzbergen, August 14, 2020. H&R GmbH & Co. KGaA (abbrev.: H&R KGaA, ISIN DE000A2E4T77) ended the first half of 2020 with an operating result (EBITDA*) of EUR 16.6 million (first half of 2019: 39.7 million). EBIT amounted to EUR -8.7 million as a result of this year's higher depreciation (first half of 2019: EUR 18.0 million), Net result attributable to shareholders closed at EUR -13.6 million (first half of 2019: EUR 10.1 million). Earnings per share amounted to EUR -0.37. Due to the weaker sales in the second quarter of 2020 - resulting from lower sales volumes - revenues of EUR 441.8 million did not come close to the comparative value of the previous year (first half of 2019: EUR 550.0 million).

Overview of the main key figures:

in EUR Million H1-2020 H1-2019 Diff. abs.
Sales revenues 441.8 550.0 -108.2
Operating income (EBITDA*) 16.6 39.7 -23.1
EBIT -8.7 18.0 -26.7
Earnings before income tax -12.7 14.0 -26.7
Net profit/loss to shareholders -13.6 10.1 -23.7
Consolidated income per share (in EUR) -0.37 0.27 -0.64
Operating cash flow 39.4 51.1 -11.7
Free cash flow 13.6 20.9 -7.3
  Q2-2020 Q2-2019 Diff. abs.
Sales revenues 182.4 263.9 -81.5
Operating income (EBITDA) 5.9 19.7 -13.8
EBIT -6.7 8.6 -15.3
Earnings before income tax -9.0 6.7 -15.7
Net profit/loss to shareholders -8.9 5.0 -13.9
Consolidated income per share (in EUR) -0.24 0.13 -0.37
Operating cash flow 36.5 7.5 29.0
Free cash flow 35.8 -4.5 31.3
  6/30/2020 12/31/2019 Diff. abs.
Balance sheet total 781.8 838.6 -56.8
Group equity 346.8 363.4 -16.6
Equity ratio (in %, difference in percentage points) 44.4 43.3 1.1
 

* Consolidated income before tax, other financial income and expenses and depreciation/amortization, impairment and appreciation of fixed assets and property, plant and equipment

The ChemPharm Sales segment again made the major contribution to earnings. Nevertheless, our international activities recorded lower operating results overall this year at EUR 11.4 million in the first half of the year (H1-2019: EUR 15.2 million). At EUR 150.9 million, sales revenues in the first half of the year were significantly below the previous year (H1-2019: EUR 188.0 million). The ChemPharm Refining segment suffered the most significant losses. Despite the six-month period EBITDA of EUR 7.0 million (1st half of 2019: EUR 22.9 million), there is a noticeable recovery for the refineries from June on. Sales in the segment decreased strongly and reached EUR 276.9 million for the first half of the year (H1-2019: EUR 345.4 million). The Plastics segment generated an almost balanced, compared to the previous year even improved operating result, both at quarterly level and for the first half of 2020. It achieved EUR -0.1 million (H1-2019: EUR -0.4 million). Revenue declined to EUR 18.2 million compared to the previous year (H1-2019: EUR 22.0 million), also as a result of the closings of many car manufacturers and automotive suppliers.

The corona pandemic and its effects hit the company hard in the first half of the year. Fortunately, we were able to record significantly improved sales and earnings figures again at the end of the half year. Despite the uncertainty, there were also more dynamics in sales volumes and customer orders, so that - based on the current state of knowledge - H&R assumes that it may have left the low point behind. Based on the previous expectation of a minimum EBITDA of € 50.0 million, the current framework data nevertheless requires readjustments: H&R currently assumes an EBITDA of a maximum of € 45.0 million.

For detailed statements on current and future business and earnings development, the company refers to the semi-annual report as of June 30, 2020 published today, which can be downloaded from H&R KGaA in the "Publications" area at www.hur.com.

 

Contact information:
H&R GmbH & Co. KGaA, Head of Investor Relations/Communications, Ties Kaiser
Neuenkirchener Strasse 8, 48499 Salzbergen
Phone.: +49 40 43218-321, Fax: +49 40 43218-390
Email: ties.kaiser@hur.com
www.hur.com

H&R GmbH & Co. KGaA:
H&R KGaA is a specialty-chemicals company listed on the Frankfurt Stock Exchange's Prime Standard segment. It develops and manufactures crude-oil-based chemical and pharmaceutical specialty products and produces high-precision plastic parts.

Forward-looking statements and forecasts:
This press release contains forward-looking statements. The statements are based on the current estimates and forecasts by the Executive Board and the information available to the Board at this time. These forward-looking statements do not provide any warranty for the future developments and results contained therein. The future developments and results are dependent on a number of factors; they entail various risks and contingencies and are based on assumptions which could prove to be incorrect. We do not assume any responsibility for updating the forward-looking statements contained in this press release.



14.08.2020 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


Language: English
Company: H&R GmbH & Co. KGaA
Neuenkirchener Str. 8
48499 Salzbergen
Germany
Phone: +49 (0)40 43 218 321
Fax: +49 (0)40 43 218 390
E-mail: investor.relations@hur.com
Internet: www.hur.com
ISIN: DE000A2E4T77
WKN: A2E4T7
Listed: Regulated Market in Dusseldorf, Frankfurt (Prime Standard), Hamburg; Regulated Unofficial Market in Berlin, Hanover, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 1118141

 
End of News DGAP News Service

1118141  14.08.2020 

fncls.ssp?fn=show_t_gif&application_id=1118141&application_name=news&site_id=boersengefluester_html


Die wichtigsten Finanzdaten auf einen Blick
  2013 2014 2015 2016 2017 2018 2019 2020e
Umsatzerlöse1 1.214,40 1.058,62 982,91 942,65 1.025,11 1.114,15 1.075,32 960,00
EBITDA1,2 32,60 31,50 86,00 101,40 97,39 74,70 52,90 42,50
EBITDA-Marge3 2,68 2,98 8,75 10,76 9,50 6,70 4,92 4,43
EBIT1,4 -4,48 5,70 48,89 54,16 54,29 40,17 7,40 -9,30
EBIT-Marge5 -0,37 0,54 4,97 5,75 5,30 3,61 0,69 -0,97
Jahresüberschuss1 -14,04 -15,61 27,26 39,29 29,50 22,32 0,08 -19,00
Netto-Marge6 -1,16 -1,47 2,77 4,17 2,88 2,00 0,01 -1,98
Cashflow1,7 88,94 -0,36 56,43 75,45 46,19 23,32 95,86 80,00
Ergebnis je Aktie8 -0,47 -0,49 0,77 1,07 0,88 0,59 -0,04 -0,52
Dividende8 0,00 0,00 0,00 0,00 0,40 0,00 0,00 0,00
Quelle: boersengefluester.de und Firmenangaben

  Geschäftsbericht 2019 - Kostenfrei herunterladen.  
1 in Mio. Euro; 2 EBITDA = Ergebnis vor Zinsen, Steuern und Abschreibungen; 3 EBITDA in Relation zum Umsatz; 4 EBIT = Ergebnis vor Zinsen und Steuern; 5 EBIT in Relation zum Umsatz; 6 Jahresüberschuss (-fehlbetrag) in Relation zum Umsatz; 7 Cashflow aus der gewöhnlichen Geschäftstätigkeit; 8 in Euro; Quelle: boersengefluester.de

Wirtschaftsprüfer: Warth & Klein Grant Thornton

INVESTOR-INFORMATIONEN
©boersengefluester.de
H&R
WKN Kurs in € Einschätzung Börsenwert in Mio. €
A2E4T7 5,520 Kaufen 205,46
KGV 2021e KGV 10Y-Ø BGFL-Ratio Shiller-KGV
27,60 13,14 2,100 14,88
KBV KCV KUV EV/EBITDA
0,67 2,14 0,19 7,729
Dividende '19 in € Dividende '20e in € Div.-Rendite '19e
in %
Hauptversammlung
0,00 0,00 0,00 29.05.2020
Q1-Zahlen Q2-Zahlen Q3-Zahlen Bilanz-PK
15.05.2020 14.08.2020 13.11.2020 08.04.2020
Abstand 60Tage-Linie Abstand 200Tage-Linie Performance YtD Performance 52 Wochen
-0,16% 12,38% 3,37% -10,24%
    
Weitere Ad-hoc und Unternehmensrelevante Mitteilungen zu H&R GmbH & Co. KGaA  ISIN: DE000A2E4T77 können Sie bei DGAP abrufen

Chemie , A2E4T7 , 2HRA , XETR:2HRA